Erdheim Chester disease (ECD) is a rare histiocytic neoplasm characterized by recurrent activating mutations in the mitogen-activated protein kinase – extracellular signal-regulated kinase (MAPK-ERK [RAS-RAF-MEK-ERK]) pathway, most commonly BRAFV600E [1]. This evidence concerns the gene MAP2K7 and histiocytic neoplasm.